TRPM2 and breast adenocarcinoma: TRPM2 displayed a defensive action in human breast adenocarcinoma cell lines to minimize DNA destruction, where cell proliferation declined and DNA damage climbed up significantly through pharmacological cessation of TRPM2 including 2-APB or TRPM2 mRNA silencing [100].